CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane

D Brugnoni1, P Airò, M Lebovitz

  • 1Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy.

Insights

Common Variable Immunodeficiency (CVID) involves impaired antibody production. This study found reduced CD40 Ligand (CD40L) expression on T-cells in CVID patients, indicating a potential T-cell defect contributing to the condition.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Common Variable Immunodeficiency (CVID) is defined by inadequate antibody production, potentially stemming from B-cell or T-cell dysfunction.
  • Defective expression of CD40 Ligand (CD40L), crucial for T-cell to B-cell signaling, has been observed in some CVID patients.

Purpose of the Study:

  • To investigate intrinsic functional abnormalities in CD4+ lymphocytes contributing to defective CD40L expression in CVID.
  • To quantify CD40L expression on CD4+ cells in CVID patients compared to healthy controls.

Main Methods:

  • Purification of CD4+ lymphocytes from eight CVID patients and eight age-matched controls.
  • Stimulation of purified CD4+ cells with PMA/Ionomycin.
  • Flow cytometry analysis of CD40L expression using specific monoclonal antibodies.

Main Results:

  • A significant reduction in the percentage of CD40L-expressing CD4+ cells was observed in CVID patients compared to controls, even after age-matching.
  • A decreased density of CD40L expression on CD4+ cells was noted in CVID patients.
  • CD40L expression levels correlated with age in both CVID patients and healthy individuals.

Conclusions:

  • The findings suggest intrinsic functional abnormalities in CD4+ lymphocytes, specifically reduced CD40L expression, contribute to CVID pathogenesis.
  • The defect in CD40L expression is variable among CVID patients and may be marginal in some cases.
Abstract